Extraordinary General Meeting of BAC’s shareholders postponed until June 3, 2022, at 10:00 a.m., Eastern Time NEW YORK and SOUTH SAN FRANCISCO, May 31, 2022 /PRNewswire/ — Biotech Acquisition Company (NASDAQ: BIOT) (“BAC“), a publicly traded special purpose acquisition company affiliated … Continue reading Biotech Acquisition Company and Blade Therapeutics Announce Postponement of Extraordinary Meeting of Shareholders to Approve Proposed Business Combination